Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Panos Fidias"'
Autor:
Panos Fidias
Publikováno v:
Journal of Thoracic Oncology. 12:S167-S169
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f172cd30154ce9806b5cee8abe5a4459
https://doi.org/10.1016/j.jtho.2016.11.150
https://doi.org/10.1016/j.jtho.2016.11.150
Autor:
Frank C. Detterbeck, Hiran C. Fernando, John R. Handy, Scott Firestone, Panos Fidias, Candice Johnstone, Ross M. Bremner, Helen J. Ross, John D. Mitchell, Kenneth A. Kesler, Thomas K. Varghese, Harvey I. Pass, Michael Lanuti, Virginia R. Litle, Todd S. Crocenzi
Publikováno v:
The Annals of thoracic surgery. 107(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b879e1fa09fba5b1f0563cf0765ed83
https://pubmed.ncbi.nlm.nih.gov/31761266
https://pubmed.ncbi.nlm.nih.gov/31761266
Publikováno v:
New England Journal of Medicine. 373:1458-1467
A 29-year-old man presented with diarrhea of 1 month's duration. He had received a diagnosis of thymoma 5 years earlier; diarrhea developed during treatment with an investigational drug and worsened despite discontinuation of the drug. Diagnostic pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::665674baa9f4e2f75d6e45aca94902c5
https://doi.org/10.1056/nejmcpc1406663
https://doi.org/10.1056/nejmcpc1406663
Publikováno v:
New England Journal of Medicine. 370:2132-2140
A 64-year-old man was admitted to the hospital with recurrent pleuritic chest pain. Imaging showed a loculated left pleural effusion and underlying consolidation in the left lower lobe. Treatment with antibiotics brought some improvement, but pain re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adec5d2a6f73abc31fc87c70e4099877
https://doi.org/10.1056/nejmcpc1400835
https://doi.org/10.1056/nejmcpc1400835
Autor:
Noah C. Choi, Douglas J. Mathisen, Tristen Chun, Thomas J. Lynch, Richard L. Kradin, Andrzej Niemierko, Alan J. Fischman, Marek Ancukiewicz, Panos Fidias
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose We investigated the metabolic response of lung cancer to radiotherapy or chemoradiotherapy by 18F-FDG PET and its utility in guiding timely supplementary therapy. Methods Glucose metabolic rate (MRglc) was measured in primary lung cancers dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af17a159133c3b61a4dd913549d7f04e
https://doi.org/10.1007/s00259-013-2348-4
https://doi.org/10.1007/s00259-013-2348-4
Autor:
Rebecca S. Heist, Alice T. Shaw, Alona Muzikansky, Meghan Campo, Jennifer S. Temel, Jeffrey A. Engelman, David E. Gerber, Justin F. Gainor, Panos Fidias, Lecia V. Sequist
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(11)
Objectives The mechanisms of acquired resistance to the irreversible EGFR inhibitor afatinib are not well documented. We performed this prospective clinical trial to determine the prevalence of the mutation T790M in afatinib-resistant patients. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbaf53bd45622c913cef33c70526d4e
https://pubmed.ncbi.nlm.nih.gov/27553514
https://pubmed.ncbi.nlm.nih.gov/27553514
Autor:
Dean M. Donahue, Jeffrey A. Engelman, Noah C. Choi, Michael Lanuti, Ashok Muniappan, Rebecca S. Heist, Anthony J. Iafrate, José Baselga, Alice T. Shaw, Jennifer S. Temel, Lecia V. Sequist, Colleen L. Channick, Panos Fidias, John C. Wain, Sarah B. Goldberg, Darrell R. Borger, Rachel P. Rosovsky, E. Bast, Cameron D. Wright, Mari Mino-Kenudson, Belinda A. Waltman, Justin F. Gainor, Swathi Tammireddy, Laura Morrissey, Thomas J. Lynch, Douglas J. Mathisen, Henning A. Gaissert, Leif W. Ellisen, Subba R. Digumarthy, Inga T. Lennes, Alona Muzikansky, Henning Willers, Dora Dias-Santagata
Publikováno v:
Annals of Oncology. 22:2616-2624
Background: Personalizing non-small-cell lung cancer (NSCLC) therapy toward oncogene addicted pathway inhibition is effective. Hence, the ability to determine a more comprehensive genotype for each case is becoming essential to optimal cancer care. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e03d1e8a3b807b1c42567b8c0fecd8b
https://doi.org/10.1093/annonc/mdr489
https://doi.org/10.1093/annonc/mdr489
Autor:
Joel W. Neal, Thomas J. Lynch, Rebecca S. Heist, J. Paul Marcoux, Mark S. Huberman, Lecia V. Sequist, Panos Fidias, Alona Muzikansky, Jennifer S. Temel
Publikováno v:
Journal of Thoracic Oncology. 5(11):1855-1858
Introduction: Therapeutic agents directed against the epidermal growth factor receptor (EGFR) signaling pathway have been effective in the treatment of non-small cell lung cancer (NSCLC). Cetuximab is a monoclonal antibody against the EGFR receptor w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999d764666e8f186d17ccf73889af297
Autor:
David C. Caldwell, Thomas J. Lynch, Marsha Jones, Jennifer S. Temel, Tatjana Kolevska, Michael S. Rabin, Lecia V. Sequist, Panos Fidias, Mark S. Huberman, Craig W. Englund, Gail L. Brown, James G. Keck, Martin J. Edelman, Lisa Meng, Ralph V. Boccia, Ostap Melnyk, Howard A. Burris, R. J. Belt, Glenn Mills
Publikováno v:
Journal of Thoracic Oncology. 4:1389-1396
Introduction We aimed to evaluate the safety and efficacy of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy in patients with locally advanced or metastatic non-small cell lung cancer. Methods This was a phase 1-2a,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194af7d39cde2522b5595453bca5114c
https://doi.org/10.1097/jto.0b013e3181b6b84b
https://doi.org/10.1097/jto.0b013e3181b6b84b
Autor:
Panos Fidias, Nathan A. Pennell, T Jesse Kwoh, Richard S. Geary, Geoffrey I. Shapiro, Anthony L. Boral, Joseph Paul Eder, Bruce E. Johnson, Thomas J. Lynch, Jeffrey G. Supko, Arthur T. Skarin
Publikováno v:
Journal of Thoracic Oncology. 4(9):1156-1162
Background A phase I trial was performed to evaluate the administration of carboplatin/paclitaxel in combination with ISIS-5132, a phosphorothioate antisense oligodeoxynucleotide inhibitor of c- raf -1 kinase expression, in patients with advanced non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8c3871285b07ffe65469c12ad7af9ff